Pharmion's P2P Acquisition

Pharmion raised a round of funding on March 10, 2008. Investors include Celgene.

Pharmion is a specialty pharmaceutical company focused on licensing, developing and commercializing therapeutic products for the treatment of hematology and oncology patients. Approved products includ…

Articles about Pharmion's P2P Acquisition: